Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Kromeriz

7 clinical trials in Kromeriz, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Kromeriz at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Kromeriz

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Ferring Pharmaceuticals A/S
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:NADOFARAGENE FIRADENOVEC
  • Sponsor:Ferring Pharmaceuticals A/S
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Atrial fibrillation

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Kromeriz

What the registry says about research in the country

01 Cardiovascular Disease Research

Innovative studies focusing on lipoprotein management and cardiovascular risk reduction in patients with established heart conditions.

  • Major cardiovascular events prevention
  • Advanced lipid-modifying therapies
  • Atherosclerotic disease management

These trials aim to evaluate novel therapeutic approaches for improving cardiovascular outcomes.

02 Heart Failure Studies

Research examining heart failure management with particular focus on acute decompensated conditions and mortality reduction.

  • Heart failure event reduction
  • Cardiovascular mortality prevention
  • HFmrEF/HFpEF treatment

Clinical investigations targeting improved outcomes in heart failure patients through innovative therapeutic approaches.

03 Atrial Fibrillation Research

Studies evaluating new treatments for atrial fibrillation, comparing novel anticoagulants with established therapies.

  • Stroke prevention
  • Bleeding risk management
  • Cardioembolic event prevention

Groundbreaking research comparing different therapeutic options for managing irregular heart rhythms and preventing complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.